The novel antibody therapies market for advanced stage drugs is anticipated to grow at a CAGR of 36% by 2035
Owing to the recent approval of therapies, such as Elzonris®, Pluvicto®, there has been a…
Owing to the recent approval of therapies, such as Elzonris®, Pluvicto®, there has been a…